Cargando…
Rethinking Human Embryo Research Policies
It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. The fourteen‐day limit was adopted as a compromise but subsequently has been consi...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986614/ https://www.ncbi.nlm.nih.gov/pubmed/33630327 http://dx.doi.org/10.1002/hast.1215 |
_version_ | 1783668476952444928 |
---|---|
author | Matthews, Kirstin R. W. Iltis, Ana S. Marquez, Nuria Gallego Wagner, Daniel S. Robert, Jason Scott de Melo‐Martín, Inmaculada Bigg, Marieke Franklin, Sarah Holm, Soren Metzler, Ingrid Molè, Matteo A. Taupitz, Jochen Testa, Giuseppe Sugarman, Jeremy |
author_facet | Matthews, Kirstin R. W. Iltis, Ana S. Marquez, Nuria Gallego Wagner, Daniel S. Robert, Jason Scott de Melo‐Martín, Inmaculada Bigg, Marieke Franklin, Sarah Holm, Soren Metzler, Ingrid Molè, Matteo A. Taupitz, Jochen Testa, Giuseppe Sugarman, Jeremy |
author_sort | Matthews, Kirstin R. W. |
collection | PubMed |
description | It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. The fourteen‐day limit was adopted as a compromise but subsequently has been considered an ethical line. Does it remain relevant in light of technological advances permitting embryo maturation beyond it? Should it be changed and, if so, how and why? What justifications would be necessary to expand the limit, particularly given that doing so would violate some people's moral commitments regarding human embryos? Robust stakeholder engagement preceded adoption of the fourteen‐day limit and should arguably be part of efforts to reassess it. Such engagement could also consider the need for enhanced oversight of human embryo research. In the meantime, developing and implementing reliable oversight systems should help foster high‐quality research and public confidence in it. |
format | Online Article Text |
id | pubmed-7986614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79866142021-03-25 Rethinking Human Embryo Research Policies Matthews, Kirstin R. W. Iltis, Ana S. Marquez, Nuria Gallego Wagner, Daniel S. Robert, Jason Scott de Melo‐Martín, Inmaculada Bigg, Marieke Franklin, Sarah Holm, Soren Metzler, Ingrid Molè, Matteo A. Taupitz, Jochen Testa, Giuseppe Sugarman, Jeremy Hastings Cent Rep Articles It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. The fourteen‐day limit was adopted as a compromise but subsequently has been considered an ethical line. Does it remain relevant in light of technological advances permitting embryo maturation beyond it? Should it be changed and, if so, how and why? What justifications would be necessary to expand the limit, particularly given that doing so would violate some people's moral commitments regarding human embryos? Robust stakeholder engagement preceded adoption of the fourteen‐day limit and should arguably be part of efforts to reassess it. Such engagement could also consider the need for enhanced oversight of human embryo research. In the meantime, developing and implementing reliable oversight systems should help foster high‐quality research and public confidence in it. John Wiley and Sons Inc. 2021-02-25 2021 /pmc/articles/PMC7986614/ /pubmed/33630327 http://dx.doi.org/10.1002/hast.1215 Text en © 2021 The Authors. Hastings Center Report published by Wiley Periodicals LLC on behalf of The Hastings Center. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Articles Matthews, Kirstin R. W. Iltis, Ana S. Marquez, Nuria Gallego Wagner, Daniel S. Robert, Jason Scott de Melo‐Martín, Inmaculada Bigg, Marieke Franklin, Sarah Holm, Soren Metzler, Ingrid Molè, Matteo A. Taupitz, Jochen Testa, Giuseppe Sugarman, Jeremy Rethinking Human Embryo Research Policies |
title | Rethinking Human Embryo Research Policies |
title_full | Rethinking Human Embryo Research Policies |
title_fullStr | Rethinking Human Embryo Research Policies |
title_full_unstemmed | Rethinking Human Embryo Research Policies |
title_short | Rethinking Human Embryo Research Policies |
title_sort | rethinking human embryo research policies |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986614/ https://www.ncbi.nlm.nih.gov/pubmed/33630327 http://dx.doi.org/10.1002/hast.1215 |
work_keys_str_mv | AT matthewskirstinrw rethinkinghumanembryoresearchpolicies AT iltisanas rethinkinghumanembryoresearchpolicies AT marqueznuriagallego rethinkinghumanembryoresearchpolicies AT wagnerdaniels rethinkinghumanembryoresearchpolicies AT robertjasonscott rethinkinghumanembryoresearchpolicies AT demelomartininmaculada rethinkinghumanembryoresearchpolicies AT biggmarieke rethinkinghumanembryoresearchpolicies AT franklinsarah rethinkinghumanembryoresearchpolicies AT holmsoren rethinkinghumanembryoresearchpolicies AT metzleringrid rethinkinghumanembryoresearchpolicies AT molematteoa rethinkinghumanembryoresearchpolicies AT taupitzjochen rethinkinghumanembryoresearchpolicies AT testagiuseppe rethinkinghumanembryoresearchpolicies AT sugarmanjeremy rethinkinghumanembryoresearchpolicies |